Navigation Links
Deep Sleep May Improve Colonoscopy Results
Date:6/1/2009

Study findings could have lifesaving potential

MONDAY, June 1 (HealthDay News) -- Putting patients into a deep sleep during colonoscopy results in more frequent detection of precancerous polyps than merely making patients sleepy with sedatives, new research has found.

During colonoscopy, patients can either be put to sleep under deep sedation or kept awake using moderate conscious sedation, which allows them to hear and respond to directions during the procedure.

Researchers found that placing patients under deep sedation resulted in the detection of more polyps, clumps of cells that form on the colon lining that may eventually become cancerous, according to a news release from the American Gastroenterological Association.

The reason could be that during deep sedation, patients are more relaxed and physicians can focus completely on polyp detection, the researchers said.

The findings are to be presented Tuesday at Digestive Disease Week 2009 in Chicago.

In the study, the researchers examined a database of endoscopy (the procedure used in colonoscopy) reports from 61 sites across the United States. Patients were either deeply sedated or given moderate conscious sedation.

Gastroenterologists found 25 percent more polyps in patients under deep sedation after controlling for age, gender and race. Doctors also found more large polyps, which are likelier to become cancerous than small ones.

"We don't know for sure whether these polyps would have been found if the patients were examined under moderate sedation," said study author Dr. Katherine M. Hoda, senior fellow in the department of gastroenterology at Oregon Health & Science University. "Our study suggests that deep sedation finds more polyps, which could have an impact on the way physicians conduct colonoscopies."

Still, the study involved a small number of patients and was not randomized, so more research needs
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Time to Set Kids Back-to-School Sleep Clocks
2. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
3. Sleepless Kids Are Troubled Kids
4. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
5. Work time is the largest influence to the duration of a persons sleep
6. Passive smoking increases sleep disturbance among pregnant women
7. Minorities more likely to have sleep durations associated with increased mortality
8. Lack of sleep among new school-goers leads to behavioral, cognitive problems
9. Work Time Predicts Sleep Time
10. Nicotine in breast milk disrupts infants sleep patterns
11. Pain patients at risk for sleep apnea
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Deep Sleep May Improve Colonoscopy Results 
(Date:5/21/2013)... May 21, 2013 Two executives from ... (SBG) will identify which strategies can be most effective ... care to the members who are taking them, in ... Inc., “How to Manage Specialty Drugs to Reduce ... are now the main driver for rising prescription drug ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The American ... million people in the United States of America are ... are at a great risk of developing peripheral neuropathy ... normal lives. The ADA further goes on saying that ... years and around 2 million new cases are diagnosed ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay ... steroid therapy for patients having severe bouts of chronic ... Five days of glucocorticoid treatment with prednisone to treat ... days, but with fewer chances for adverse side effects, ... shorter period of treatment was not less effective than ...
(Date:5/21/2013)... that it is a Grand Challenges Explorations winner, ... Gates Foundation. Tae Seok Moon, PhD, assistant professor ... an innovative global health and development research project ... Organisms." , Grand Challenges Explorations (GCE) funds individuals ... mold in how we solve persistent global health ...
(Date:5/21/2013)... As many as 35 percent of Mexican young adults ... University of Illinois scientist who conducted a study at ... students who inherited genetic risk factors from both parents ... around the waist than those who hadn,t. They also ... a U of I professor of food science and ...
Breaking Medicine News(10 mins):Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Gates Fellowship addresses parasite infection in developing world 2Health News:Genetic risk for obesity found in many Mexican young adults 2
... 24 (HealthDay News) -- Morbidly obese patients who undergo spinal ... and also face higher hospital costs, a new study says. ... spinal pain. People with a body mass index (BMI) of ... generally 50 to 100 percent over their ideal body weight, ...
... , WEDNESDAY, May 23 (HealthDay News) -- The risk of ... travel more slowly through the lower chambers of the heart, ... heart and cause it to pump blood through its four ... be measured using an electrocardiogram (ECG). The waves traveling through ...
... the most comprehensive analyses to date of the cost of ... that this now-dominant surgical approach is significantly more costly than ... patient outcomes. The results of the study are available online ... Urology . In one of the first ...
... that maintain healthy nerve connections as we age help keep ... charity Age UK has found. Older people with robust ... different, distant brain areas can process information quickly and ... According to the findings, joining distant parts of the ...
... , WEDNESDAY, May 23 (HealthDay News) -- The ... reduced through a multi-pronged approach that includes more training ... to a new German study. Despite legal regulations ... as bed rails and belts still are frequently used ...
... Minn. -- Mayo Clinic researchers will present findings on ... at the annual meeting of the American Urological Association ... be available to provide expert comment for reporters covering ... presented and their embargo dates include: No ...
Cached Medicine News:Health News:Severely Obese Have More Complications With Spinal Surgery 2Health News:Study Spots Early Warning Signal for Sudden Cardiac Death 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Well-connected brains make you smarter in older age 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
(Date:5/21/2013)... , May 21, 2013  Janssen R&D Ireland ... from the global Phase 3 PROMISE study demonstrating ... (TMC435) led to sustained virologic response 12 weeks ... percent of treatment-experienced genotype 1 chronic hepatitis C ... stages of liver fibrosis, when administered once daily ...
(Date:5/21/2013)... 2013  BioRestorative Therapies, Inc. ("BRT" or the "Company") ... developing stem cell based therapies for various personal applications, ... President and CEO, will be presenting at the Marcum ... held on Thursday, May 30, 2013 at the Grand ... New York City.  Mr. Weinreb,s presentation will take place ...
(Date:5/21/2013)... , May 21, 2013 STAAR Surgical Company ... and marketer of minimally invasive ophthalmic products, today announced ... to review the Company,s recent financial results and business ... Surgical will present at the 38 th Annual ... at the Westin Waterfront Hotel on Wednesday, ...
Breaking Medicine Technology:Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3STAAR Surgical To Present At Upcoming Investor Conferences 2
... from Cytel join peers in examining the rise of ... ... CAMBRIDGE, Mass., June 23 Cytel,s renowned adaptive,trial design and implementation ... will lead workshops and case,study reviews at the Annual Meeting of ...
... 23 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) ... Annual Scientific Meeting of,the American Headache Society, which ... Boston, MA. The oral platform abstract presentation,"Inhaled Loxapine, ...
Cached Medicine Technology:Cytel's Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting 2Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting 2
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Maximum contact. Minimum wear. Outstanding results....
...
...
Medicine Products: